Description

Debiglip 100 SR Tablet contains Vildagliptin 100 mg, a DPP-4 inhibitor used for the management of type 2 diabetes mellitus when diet and exercise alone are not sufficient. It works by increasing the levels of certain hormones (incretins) that stimulate insulin release and reduce glucagon secretion, thereby helping to control blood sugar levels, especially after meals. It can be used alone or in combination with other antidiabetic medicines such as metformin or sulfonylureas.

Uses:

• Helps control blood sugar in adults with type 2 diabetes

• Reduces fasting and post-meal glucose levels

• Can be combined with other antidiabetic drugs for better glycemic control

• Supports prevention of diabetes-related complications when taken regularly with lifestyle changes

Side Effects:
Most people tolerate Debiglip 100 SR well, but possible side effects include:

• Common: Headache, dizziness, tremors, fatigue, nausea, constipation, diarrhea, stomach discomfort

• Occasional: Upper respiratory tract infection, joint pain, blurred vision, mild skin rash

• Rare: Low blood sugar (more likely when combined with other sugar-lowering medicines), liver enzyme changes, allergic reactions

Precautions:
Not recommended in pregnancy or breastfeeding without medical advice. Use with caution in liver or kidney disease. Monitor blood sugar regularly, and seek medical attention if persistent side effects or unusual symptoms occur.